Hello Share Followers. The medical sector is likely to pay more juicy dividends in the humble view of this old punter. Covid has concentrated minds on the need to pour more dosh into the NHS and other services to meet a growing demand from an ageing population and to deal with the huge logjam caused by the pandemic. So let’s take a peek at ConvaTec Group (CTEC).
Shares in ConvaTec (CTEC) - whose products are used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions - have come a little more my way recently as I discussed here a couple of weeks ago. Today's regulatory news announcement by the company caused me - however - to raise my eyebrows slightly…
I do not think it is too controversial to observe that on 90%+ of issues our former in house 'bulletin board loon' Wildes - who used to be not shy of posting a view or ten in the comments section on many articles - was way off the mark. However I have to give the old loon a hat tip on the specific issue of ConvaTec (CTEC) which I posted on a year ago and on which Wildes prophetically observed I was talking sh1t quite literally.
We should not laugh about colostomy bags as there is a reasonable chance of being hooked up to one at some point. Good news then that medical products company ConvaTec (CTEC) notes that at its 'R&D centre in North Wales, scientists and technicians show off a better lubricated catheter; a tighter sealant for an “ostomy” bag used to collect colostomy waste; and an agent that, when applied to an infected wound, changes colour according to the severity of infection to allow more rapid treatment'.
